NCT03277092

Brief Summary

Reaching a peripheral venous access or making a blood sample in a scared infant or toddler can be challenging even for experienced nurses o pediatricians. Up to 60% of children report pain and distress during venipuncture and multiple attempts can result in more difficult physical and emotional conditions for subsequent insertions so that the procedure should be performed with the less number of punctures as possible. In about one third of children, more than one attempt is required to achieve peripheral intravenous cannulation. In the last years, specific tools have been developed to enhance the success in venipuncture or incannulation. Near-infrared (NIR) technology consists on light-emitting diodes placed underneath the hand, that makes vessels visible by projecting the processed image in a green light directly on to the puncture site. According to previous studies, NIR had shown a trend in reduction of time employed for a blood sample, in children younger of 6 yr. The aim of this trial is to investigate if the use of the VeinViewer® in a pediatric blood drawing center could decrease time spent to perform the procedure and improve the rate of first attempt success.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
24 days until next milestone

Study Start

First participant enrolled

October 2, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2017

Completed
Last Updated

November 30, 2017

Status Verified

June 1, 2017

Enrollment Period

2 months

First QC Date

September 7, 2017

Last Update Submit

November 29, 2017

Conditions

Keywords

Child, blood drawing procedure, near Infrared light

Outcome Measures

Primary Outcomes (1)

  • Time to perform the procedure

    In seconds, from the placement of the tourniquet until the blood flows in the needle

    Intraprocedural

Secondary Outcomes (1)

  • Success at first attempt

    Intraprocedural

Study Arms (2)

VeinViewer® group

EXPERIMENTAL

Use of near infrared light to perform blood draw (VeinViewer®)

Device: VeinViewer®

Usual care group

ACTIVE COMPARATOR

Blood drawing performed traditionally

Procedure: Usual care

Interventions

Near-infrared (NIR) technology consists on light-emitting diodes placed underneath the hand, that makes vessels visible by projecting the processed image in a green light directly on to the puncture site

VeinViewer® group
Usual carePROCEDURE

The blood drawing is performed traditionally

Usual care group

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • subjects accessing the outpatient blood-drawing service

You may not qualify if:

  • application of topical anaesthetic cream

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Burlo Garofolo

Trieste, 34137, Italy

Location

Related Publications (1)

  • Conversano E, Cozzi G, Pavan M, Minute M, Gortan E, Montico M, Vecchi Brumatti L, Ronfani L, Barbi E. Impact of near infrared light in pediatric blood drawing Centre on rate of first attempt success and time of procedure. Ital J Pediatr. 2018 May 25;44(1):60. doi: 10.1186/s13052-018-0501-1.

Study Officials

  • Egidio Barbi, MD PhD

    IRCCS Burlo Garofolo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2017

First Posted

September 8, 2017

Study Start

October 2, 2017

Primary Completion

November 28, 2017

Study Completion

November 28, 2017

Last Updated

November 30, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations